A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma

A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma

NK/T-cell lymphoma (NKTCL) is a rare type of non-Hodgkin lymphoma (NHL). Although L-asparaginase-based chemotherapy has significantly improved survival in early-stage patients, the prognosis is poor in advanced and relapsed or refractory patients. CD47 is a promising target for cancer immunotherapy....

Full description

Saved in:
Bibliographic Details
Main Authors: Liping Qin, Yajun Li, Ruolan Zeng, Yizi He, Xiaoyan Chen, Ling Xiao, Hui Zhou
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Nk/T-cell lymphoma
CD47
monoclonal antibody
macrophage
phagocytosis
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2408088
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items